0001209191-19-059280.txt : 20191205 0001209191-19-059280.hdr.sgml : 20191205 20191205160514 ACCESSION NUMBER: 0001209191-19-059280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191203 FILED AS OF DATE: 20191205 DATE AS OF CHANGE: 20191205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TOMSICEK MICHAEL JOHN CENTRAL INDEX KEY: 0001570392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 191270461 MAIL ADDRESS: STREET 1: 28 OVERLOOK DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-03 0 0001674416 CRISPR Therapeutics AG CRSP 0001570392 TOMSICEK MICHAEL JOHN C/O CRISPR THERAPEUTICS, INC. 610 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer Restricted Stock Units 2019-12-03 4 A 0 20000 0.00 A Common Shares 20000 20000 D Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. /s/ Michael Esposito, attorney-in-fact 2019-12-05